Harnessing the evolving understanding of the importance of allergen specific IgG in regulating both immediate hypersensitivity and chronic type 2 responses in allergy, researchers have developed recombinant allergen specific IgG antibodies or molecules that bind FcγRIIb and could be used to treat IgE-mediated allergies. The gene discussed is FCGR2B; the disease is allergic disease.